T1	Participants 53 87	patients with rheumatoid arthritis
T2	Participants 320 359	patients with rheumatoid arthritis (RA)
T3	Participants 573 627	210 RA patients who participated in a randomized trial
T4	Participants 1810 1821	RA patients
